Table 2.

Subsequent cut-off thresholds for defining ER based on the prognosis

Subsequent cut-off values	P value	Potential ER cohort				Potential LR cohort
		N	RFS (mo)	PRS (mo)	OS (mo)	N	RFS (mo)	PRS (mo)	OS (mo)
8	1.28 × 10-11	19	3.5	18.0	22.7	92	16.3	31.2	62.7
9	1.40 × 10-12	23	4.7	18.2	32.0	88	17.5	31.4	62.7
10	1.35 × 10-12	25	4.7	18.7	32.3	86	18.6	31.7	63.4
11	1.02 × 10-12	27	5.8	19.2	32.8	84	19.2	31.7	63.4
12	4.02 × 10-13	32	5.9	19.5	34.2	79	19.7	32.1	64.2
13	2.68 × 10-13	34	6.2	19.9	35.0	77	20.6	32.4	64.2
14	2.00 × 10-13	37	7.9	20.1	35.8	74	21.3	32.6	68.4
15	1.54 × 10-13	40	9.3	20.6	37.3	71	22.8	32.9	76.0
16	1.34 × 10-13	42	9.7	20.7	37.3	69	23.0	33.2	77.5
17	1.04 × 10-14	50	10.3	21.0	38.2	61	23.5	33.5	78.2
18	6.15 × 10-15	52	10.7	21.4	39.6	59	24.2	33.8	78.7
19	4.37 × 10-15	54	11.3	21.7	41.2	57	26.8	34.2	81.5
20	6.89 × 10-16	58	11.6	21.9	41.5	53	27.4	34.6	83.7
21	4.18 × 10-16	60	12.4	22.2	41.7	51	28.3	35.0	84.7
22	5.64 × 10-17	64	12.9	22.4	42.4	47	29.5	35.1	83.7
23	9.64 × 10-17	67	13.2	22.7	42.2	44	30.6	35.3	85.4
24	7.92 × 10-18	71	13.5	23.0	42.9	40	31.2	35.3	82.7
25	2.05 × 10-18	75	13.8	23.5	42.9	36	32.3	35.5	84.2
26	4.89 × 10-19	76	14.1	23.7	43.7	35	33.4	35.8	83.7
27	4.93 × 10-19	79	14.7	24.1	45.6	32	35.6	36.5	85.4
28	5.17 × 10-19	81	15.3	24.2	47.3	30	36.7	37.3	86.1
29	7.99 × 10-19	83	15.8	24.7	48.5	28	37.9	38.5	87.7
30	6.48 × 10-19	84	16.2	25.3	47.9	27	40.3	39.2	89.2
31	1.09 × 10-18	87	16.7	25.7	48.7	24	41.6	39.6	94.1
34	1.24 × 10-18	88	17.0	25.9	49.1	23	42.7	40.0	96.6
36	1.96 × 10-18	90	17.4	26.1	49.5	21	44.6	40.8	101.1
44	2.13 × 10-18	92	17.9	26.5	50.5	19	45.8	40.9	117.2
45	3.86 × 10-17	94	18.3	26.8	49.5	17	47.2	41.0	126.7
47	8.13 × 10-17	95	18.6	27.0	49.5	16	48.5	41.3	143.5
48	8.33 × 10-17	96	19.1	27.3	50.5	15	49.3	42.5	160.2
53	8.86 × 10-17	98	19.7	28.2	51.7	13	50.7	57.8	179.5
56	1.96 × 10-16	99	20.3	28.9	52.0	12	51.2	58.4	193.2
77	2.24 × 10-16	101	20.5	30.2	52.2	10	53.6	58.4	206.9
100	2.66 × 10-14	103	20.8	31.9	52.4	8	54.8	59.9	219.0